The Journal of Arthroplasty
Volume 25, Issue 8 , Pages 1267-1274 , December 2010

Dabigatran Etexilate Prevents Venous Thromboembolism After Total Knee Arthroplasty in Japanese Patients With a Safety Profile Comparable to Placebo

  • Takeshi Fuji, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, Osaka Koseinenkin Hospital, Osaka, Japan
    • Corresponding Author InformationReprint requests: Takeshi Fuji, MD, PhD, Department of Orthopedic Surgery, Osaka Koseinenkin Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka 553-0003, Japan.
  • ,
  • Satoru Fuijita, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, Takarazuka Daiichi Hospital, Takarazuka, Japan
  • ,
  • Toru Ujihira, MD, PhD

      Affiliations

    • Department of Cardiology, Okayama Red Cross General Hospital, Japan
  • ,
  • Toru Sato, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, National Hospital Organization, Okayama Medical Center, Japan

Received 27 February 2009 ,Accepted 20 August 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Benefits or funds were received in particular or total support of the research material described in this article. These benefits and/or support were received from the following sources: Boehringer Ingelheim Co, Ltd (Kawanishi, Japan).

 Fuji is the coordinating investigator for Nippon Boehringer Ingelheim in this clinical study. Fujita is the chair of adjudication committee for diagnostic tests. Sato and Ujihira are consultants for Nippon Boehringer Ingelheim.

PII: S0883-5403(09)00410-0

doi: 10.1016/j.arth.2009.08.010

The Journal of Arthroplasty
Volume 25, Issue 8 , Pages 1267-1274 , December 2010